The Role of Bcl-2 Family Proteins in Therapy Responses of Malignant Astrocytic Gliomas: Bcl2L12 and Beyond

Glioblastoma (GBM) is a highly aggressive and lethal brain cancer with a median survival of less than two years after diagnosis. Hallmarks of GBM tumors include soaring proliferative indices, high levels of angiogenesis, diffuse invasion into normal brain parenchyma, resistance toward therapy-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouri, Fotini M., Jensen, Samuel A., Stegh, Alexander H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289992/
https://www.ncbi.nlm.nih.gov/pubmed/22431925
http://dx.doi.org/10.1100/2012/838916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289992/
https://www.ncbi.nlm.nih.gov/pubmed/22431925
http://dx.doi.org/10.1100/2012/838916

Ejemplares similares